- Report
- October 2023
- 80 Pages
United States
From €1339EUR$1,500USD£1,164GBP
- Report
- October 2023
- 80 Pages
United Kingdom
From €1339EUR$1,500USD£1,164GBP
From €1339EUR$1,500USD£1,164GBP
- Report
- October 2023
- 80 Pages
Saudi Arabia
From €1339EUR$1,500USD£1,164GBP
- Report
- October 2023
- 80 Pages
India
From €1339EUR$1,500USD£1,164GBP
- Report
- October 2023
- 80 Pages
Germany
From €1339EUR$1,500USD£1,164GBP
- Report
- October 2023
- 80 Pages
France
From €1339EUR$1,500USD£1,164GBP
- Report
- March 2024
- 249 Pages
Global
€4459EUR$4,995USD£3,877GBP
- Report
- September 2023
- 114 Pages
Global
From €2633EUR$2,950USD£2,290GBP
- Report
- September 2023
- 87 Pages
Africa, Middle East
From €2633EUR$2,950USD£2,290GBP
- Report
- September 2023
- 89 Pages
From €2633EUR$2,950USD£2,290GBP
- Report
- September 2023
- 107 Pages
Asia Pacific
From €3080EUR$3,450USD£2,678GBP
- Report
- September 2023
- 112 Pages
Europe
From €3080EUR$3,450USD£2,678GBP
- Report
- September 2023
- 101 Pages
North America
From €2633EUR$2,950USD£2,290GBP
- Report
- September 2023
- 194 Pages
Global
From €4419EUR$4,950USD£3,842GBP
- Report
- November 2022
- 160 Pages
Global
€3035EUR$3,400USD£2,639GBP
- Report
- September 2025
- 85 Pages
Global
From €3500EUR$4,200USD£3,150GBP
- Report
- September 2025
- 87 Pages
Global
From €3500EUR$4,200USD£3,150GBP
- Report
- August 2025
- 105 Pages
Global
From €3500EUR$4,200USD£3,150GBP
- Report
- October 2024
- 86 Pages
Global
From €3500EUR$4,200USD£3,150GBP

The Conjugate Vaccine market is a subset of the Vaccines market, which is composed of products designed to prevent and treat infectious diseases. Conjugate Vaccines are a type of vaccine that combines a polysaccharide antigen with a protein carrier, which helps the body to recognize the antigen and mount an immune response. These vaccines are used to protect against a variety of bacterial infections, including meningitis, pneumonia, and sepsis.
Conjugate Vaccines are typically administered to infants and young children, as their immune systems are not yet fully developed and are more susceptible to certain infections. In addition, these vaccines are often used in combination with other vaccines to provide broader protection against multiple diseases.
Notable companies in the Conjugate Vaccine market include GlaxoSmithKline, Merck & Co., Pfizer, Sanofi, and Novartis. Show Less Read more